Cargando…

Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?

Antibiotics once regarded as magic bullets are no more considered so. Overuse of antibiotics in humans, agriculture, and animal husbandry has resulted in the emergence of a wide range of multidrug-resistant (MDR) pathogens which are difficult to treat. Antimicrobial resistance (AMR) is a serious glo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sannathimmappa, Mohan Bilikallahalli, Nambiar, Vinod, Aravindakshan, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719572/
https://www.ncbi.nlm.nih.gov/pubmed/35071644
http://dx.doi.org/10.4103/jehp.jehp_557_21
_version_ 1784624963601301504
author Sannathimmappa, Mohan Bilikallahalli
Nambiar, Vinod
Aravindakshan, Rajeev
author_facet Sannathimmappa, Mohan Bilikallahalli
Nambiar, Vinod
Aravindakshan, Rajeev
author_sort Sannathimmappa, Mohan Bilikallahalli
collection PubMed
description Antibiotics once regarded as magic bullets are no more considered so. Overuse of antibiotics in humans, agriculture, and animal husbandry has resulted in the emergence of a wide range of multidrug-resistant (MDR) pathogens which are difficult to treat. Antimicrobial resistance (AMR) is a serious global health problem associated with high mortality in the era of modern medicine. Moreover, in the absence of an effective antibiotic, medical and surgical interventions can highly become a risk. In recent times, the decreased incline of pharmaceutical industries toward research and development of newer effective antibiotics to fight this MDR pathogens have further fuelled the scarcity of antibiotics, thus the number of antibiotics in the pipeline is extremely limited. Hence it is high time for the development of new strategies to fight against dangerous MDR pathogens. Currently, several novel approaches explored by scientists have shown promising results pertaining to their antimicrobial activity against pathogens. In this article, the authors have summarized various novel therapeutic options explored to contain AMR with special attention to the mechanism of action, advantages, and disadvantages of different approaches.
format Online
Article
Text
id pubmed-8719572
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87195722022-01-20 Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? Sannathimmappa, Mohan Bilikallahalli Nambiar, Vinod Aravindakshan, Rajeev J Educ Health Promot Review Article Antibiotics once regarded as magic bullets are no more considered so. Overuse of antibiotics in humans, agriculture, and animal husbandry has resulted in the emergence of a wide range of multidrug-resistant (MDR) pathogens which are difficult to treat. Antimicrobial resistance (AMR) is a serious global health problem associated with high mortality in the era of modern medicine. Moreover, in the absence of an effective antibiotic, medical and surgical interventions can highly become a risk. In recent times, the decreased incline of pharmaceutical industries toward research and development of newer effective antibiotics to fight this MDR pathogens have further fuelled the scarcity of antibiotics, thus the number of antibiotics in the pipeline is extremely limited. Hence it is high time for the development of new strategies to fight against dangerous MDR pathogens. Currently, several novel approaches explored by scientists have shown promising results pertaining to their antimicrobial activity against pathogens. In this article, the authors have summarized various novel therapeutic options explored to contain AMR with special attention to the mechanism of action, advantages, and disadvantages of different approaches. Wolters Kluwer - Medknow 2021-11-30 /pmc/articles/PMC8719572/ /pubmed/35071644 http://dx.doi.org/10.4103/jehp.jehp_557_21 Text en Copyright: © 2021 Journal of Education and Health Promotion https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Sannathimmappa, Mohan Bilikallahalli
Nambiar, Vinod
Aravindakshan, Rajeev
Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
title Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
title_full Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
title_fullStr Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
title_full_unstemmed Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
title_short Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
title_sort antibiotics at the crossroads – do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719572/
https://www.ncbi.nlm.nih.gov/pubmed/35071644
http://dx.doi.org/10.4103/jehp.jehp_557_21
work_keys_str_mv AT sannathimmappamohanbilikallahalli antibioticsatthecrossroadsdowehaveanytherapeuticalternativestocontroltheemergenceandspreadofantimicrobialresistance
AT nambiarvinod antibioticsatthecrossroadsdowehaveanytherapeuticalternativestocontroltheemergenceandspreadofantimicrobialresistance
AT aravindakshanrajeev antibioticsatthecrossroadsdowehaveanytherapeuticalternativestocontroltheemergenceandspreadofantimicrobialresistance